Dan Shan1, Konglong Shen2, Jing Zhu3, Mei Feng3, Yanqiu Wu3, Chun Wan3, Yongchun Shen3, Liangzhi Xu1. 1. Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University Chengdu 610041, China. 2. Radiation Physics Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu 610041, Sichuan, China. 3. Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University Chengdu 610041, China.
Abstract
BACKGROUND: Many studies suggest that the Gln261Arg polymorphism in 12-lipoxygenase gene is assicated with cancer susceptibility, but the results are inconclusive. This meta-analysis aimed to investigate the overall association between the Gln261Arg polymorphism in 12-lipoxygenase gene and cancer risk. METHODS: Literature search was performed in Pubmed, Embase and other databases for studies evaluating the association between the Gln261Arg polymorphism in 12-lipoxygenase gene and cancer risk. Data were extracted and statistical analysis was performed using STATA 12.0 software. RESULTS: A total of eight publications involving 8,379 subjects were included in this meta-analysis. Combined analysis revealed a significant association between this polymorphism and cancer susceptibility with an OR of 1.19 (95% CI: 1.09-1.31, P=0.000 for Gln/Gln vs. Arg/Gln + Arg/Arg). Subgroup analysis by ethnicity showed that the cancer risk associated with the Gln261Arg polymorphism in 12-lipoxygenase gene was significantly elevated among Asians (OR=1.21, 95% CI: 1.10-1.34, P=0.000 for Gln/Gln vs. Arg/Gln + Arg/Arg), but not among Caucasians. Subgroup analysis by cancer type suggested that the Gln261Arg polymorphism in 12-lipoxygenase gene is not a risk factor for colon cancer or rectal cancer. CONCLUSION: This meta-analysis suggests that the Gln261Arg polymorphism in 12-lipoxygenase gene contributes to cancer susceptibility, specifically in Asian populations. More studies are needed to validate our findings.
BACKGROUND: Many studies suggest that the Gln261Arg polymorphism in 12-lipoxygenase gene is assicated with cancer susceptibility, but the results are inconclusive. This meta-analysis aimed to investigate the overall association between the Gln261Arg polymorphism in 12-lipoxygenase gene and cancer risk. METHODS: Literature search was performed in Pubmed, Embase and other databases for studies evaluating the association between the Gln261Arg polymorphism in 12-lipoxygenase gene and cancer risk. Data were extracted and statistical analysis was performed using STATA 12.0 software. RESULTS: A total of eight publications involving 8,379 subjects were included in this meta-analysis. Combined analysis revealed a significant association between this polymorphism and cancer susceptibility with an OR of 1.19 (95% CI: 1.09-1.31, P=0.000 for Gln/Gln vs. Arg/Gln + Arg/Arg). Subgroup analysis by ethnicity showed that the cancer risk associated with the Gln261Arg polymorphism in 12-lipoxygenase gene was significantly elevated among Asians (OR=1.21, 95% CI: 1.10-1.34, P=0.000 for Gln/Gln vs. Arg/Gln + Arg/Arg), but not among Caucasians. Subgroup analysis by cancer type suggested that the Gln261Arg polymorphism in 12-lipoxygenase gene is not a risk factor for colon cancer or rectal cancer. CONCLUSION: This meta-analysis suggests that the Gln261Arg polymorphism in 12-lipoxygenase gene contributes to cancer susceptibility, specifically in Asian populations. More studies are needed to validate our findings.
Authors: Julie E Goodman; Elise D Bowman; Stephen J Chanock; Anthony J Alberg; Curtis C Harris Journal: Carcinogenesis Date: 2004-08-12 Impact factor: 4.944
Authors: Goodarz Danaei; Stephen Vander Hoorn; Alan D Lopez; Christopher J L Murray; Majid Ezzati Journal: Lancet Date: 2005-11-19 Impact factor: 79.321
Authors: A Susana Ramírez; Lila J Finney Rutten; April Oh; Bryan Leyva Vengoechea; Richard P Moser; Robin C Vanderpool; Bradford W Hesse Journal: J Cancer Educ Date: 2013-06 Impact factor: 2.037
Authors: Ye Wang; Liuqun Jia; Yongchun Shen; Shujin Guo; Chun Wan; Ting Yang; Jing An; Lei Chen; Tao Wang; Fuqiang Wen Journal: Int J Clin Exp Med Date: 2014-01-15
Authors: Graham P Pidgeon; Joanne Lysaght; Sriram Krishnamoorthy; John V Reynolds; Ken O'Byrne; Daotai Nie; Kenneth V Honn Journal: Cancer Metastasis Rev Date: 2007-12 Impact factor: 9.264